12-02-2024 | Hepatitis B
Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?
Published in: Current Hepatology Reports | Issue 1/2024
Login to get access